WHO ICTRP trial
The value of systemic immune-inflammation index(SII) in predicting the prognosis…
ChiCTR2300068115 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2300068115 |
|---|---|
| Public title | The value of systemic immune-inflammation index(SII) in predicting the prognosis of patients with diquat poisoning |
| Scientific title | The value of systemic immune-inflammation index(SII) in predicting the prognosis of patients with diquat poisoning |
| Primary sponsor | Affiliated Hospital of Xuzhou Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | diquat poisoning |
| Interventions | Death group and survival group:nothing |
| Registration date | Feb 7, 2023 |
| Target size | Death group and survival group:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: